Please check your internet connection and try again.
# Chymosin Forte (Chymotrypsin/Trypsin)
## Overview
Chymosin Forte is a proteolytic enzyme preparation typically containing a combination of trypsin and chymotrypsin. These enzymes are derived from bovine sources and are utilized for their purported anti-inflammatory and fibrinolytic properties by breaking down proteins at the site of inflammation or edema.
## Primary Indications
Commonly used as an adjunct for the reduction of localized edema, hematoma, and inflammation resulting from trauma, surgery, or abscesses.
## Adult Dosing
* **Standard Oral Dose:** 1 tablet (containing typical ratios of trypsin/chymotrypsin) administered 3 to 4 times daily.
* **Maximum Dose:** Generally not to exceed 4 tablets per 24 hours unless otherwise directed by local institutional protocols or specific product labeling.
## Pediatric Dosing
Safety and efficacy have not been well-established in pediatric populations. Use is generally not recommended unless specifically prescribed by a specialist. If used, dosing is often weight-based or off-label; consult local pediatric clinical pharmacists or hospital formularies for restricted pediatric protocols.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific data available. Use with caution in patients with severe underlying renal or hepatic dysfunction.
* **Geriatric:** No specific dose adjustments, but monitor for increased sensitivity to systemic effects.
## Contraindications
* Known hypersensitivity to trypsin, chymotrypsin, or any component of the formulation (often bovine-derived).
* Presence of severe generalized infections or septicemia.
* Severe coagulation disorders or patients currently on therapeutic anticoagulation (e.g., warfarin, heparin) due to theoretical risks of hemorrhage.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, or abdominal discomfort.
* **Hypersensitivity:** Rare, but potential for allergic reactions including pruritus, rash, urticaria, or anaphylaxis.
* **Hematologic:** Potential for increased systemic bleeding tendency if high doses are absorbed.
## Key Drug Interactions
* **Anticoagulants/Antiplatelets:** May potentiate the effects of anticoagulants (e.g., warfarin, clopidogrel, aspirin) or thrombolytics, increasing the risk of bleeding.
* **Antibiotics:** May increase the concentration of certain antibiotics (e.g., tetracyclines, chloramphenicol) in the blood or tissue; monitor for enhanced efficacy or toxicity.
## Monitoring
* Monitor for signs of localized healing versus worsening inflammation.
* Monitor for signs of abnormal bleeding (e.g., bruising, hematuria, prolonged epistaxis).
* Assess for signs of allergic reaction upon initiation.
## Clinical Pearls
* **Absorption:** Oral enzyme preparations have highly variable bioavailability; efficacy remains controversial in Western clinical practice due to minimal systemic absorption of intact protein molecules.
* **Timing:** Administer at least 30 minutes before meals for optimal effect, as food may interfere with enzymatic activity.
* **Storage:** Store in a cool, dry place; proteases are sensitive to temperature and moisture, which can lead to rapid degradation of potency.
* **Regulatory Note:** This product is classified differently across global markets (e.g., dietary supplement vs. pharmaceutical drug). Always check the specific country's regulatory status.
***
*Disclaimer: This information is for educational purposes only. Drug information, dosing, and availability can change. Always verify current prescribing information, institutional guidelines, and regional regulatory status through your facility's pharmacy department or official drug databases (e.g., Lexicomp, Micromedex) before administration.*
